VIMU
TMO icon

Veritas Investment Management (UK)’s Thermo Fisher Scientific TMO Stock Holding History

Veritas Investment Management (UK)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-66,719
Closed -$44.5M – 29
2021
Q4 		$44.5M Sell
66,719
-10,403
-13% -$6.5M 6.87% 2
2021
Q3 		$44.1M Sell
77,122
-2,023
-3% -$1.11M 7.23% 1
2021
Q2 		$39.9M Buy
79,145
+1,440
+2% +$679K 6.58% 3
2021
Q1 		$35.5M Buy
77,705
+2,468
+3% +$1.18M 6.61% 2
2020
Q4 		$35M Sell
75,237
-1,477
-2% -$693K 6.75% 2
2020
Q3 		$33.9M Sell
76,714
-4,311
-5% -$1.78M 7.6% 1
2020
Q2 		$29.4M Sell
81,025
-180
-0.2% -$60.3K 7.09% 4
2020
Q1 		$23M Sell
81,205
-10,089
-11% -$3.18M 6.95% 4
2019
Q4 		$29.7M Sell
91,294
-5,008
-5% -$1.52M 7.45% 4
2019
Q3 		$28.1M Sell
96,302
-155
-0.2% -$44.4K 7.74% 3
2019
Q2 		$28.3M Sell
96,457
-1,649
-2% -$454K 8.04% 3
2019
Q1 		$26.9M Sell
98,106
-8,114
-8% -$2.02M 8.33% 2
2018
Q4 		$23.8M Sell
106,220
-6,810
-6% -$1.6M 7.76% 4
2018
Q3 		$27.6M Sell
113,030
-1,730
-2% -$398K 7.6% 2
2018
Q2 		$23.8M Buy
114,760
+7,704
+7% +$1.64M 7.72% 3
2018
Q1 		$22.1M Buy
107,056
+2,148
+2% +$451K 7.5% 3
2017
Q4 		$19.9M Sell
104,908
-5,915
-5% -$1.13M 7.35% 6
2017
Q3 		$21M Buy
110,823
+1,398
+1% +$253K 7.38% 4
2017
Q2 		$19.1M Sell
109,425
-5,305
-5% -$891K 7.34% 5
2017
Q1 		$17.6M Buy
114,730
+7,235
+7% +$1.11M 6.8% 7
2016
Q4 		$15.2M Buy
+107,495
New +$15.8M 6.24% 7

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Veritas Investment Management (UK)'s TMO Position: Q1 2022 in Review

Veritas Investment Management (UK) sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 66,719 shares — an estimated $44.5M sold.

Veritas Investment Management (UK) first reported a position in TMO in Q4 2016 and held it in 21 quarters. The position peaked at $44.5M in Q4 2021. 2,315 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Veritas Investment Management (UK) reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
  • Veritas Investment Management (UK) sold 66,719 Thermo Fisher Scientific shares in Q1 2022, an estimated $44.5M.
  • Veritas Investment Management (UK) first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 21 quarters.
  • Veritas Investment Management (UK)'s Thermo Fisher Scientific position peaked at $44.5M in Q4 2021.
  • 2,315 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Veritas Investment Management (UK)'s 13F filing for Q1 2022.